Neoantigen cancer vaccine augments anti-CTLA-4 efficacy.
Salvatori E, Lione L, Compagnone M, Pinto E, Conforti A, Ciliberto G, Aurisicchio L, Palombo F. 
npj Vaccines 2022 volume 7, 15.

Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition.
Lione L, Salvatori E, Petrazzuolo A, Massacci A, Maggio R, Conforti A, Compagnone M, Aurisicchio L, Ciliberto G, Palombo F.
Oncoimmunology 2021 23;10(1):1898832.

Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth.
Aurisicchio L, Salvatori E, Lione L, Bandini S, Pallocca M, Maggio R, Fanciulli M, De Nicola F, Goeman F, Ciliberto G, Conforti A, Luberto L, Palombo F.  
J Exp Clin Cancer Res 2019, 14;38(1):78.